Skip to main content
. 2021 Feb 23;16(4):514–521. doi: 10.2215/CJN.09130620

Table 2.

Study outcomes (unadjusted analysis)

Outcomes Urine Protein-Creatinine Ratio Urine Retinol Binding Protein-Creatinine Ratio
<1 g/g, n=116 ≥1 g/g, n=84 Odds Ratio (95% Confidence Interval) P Value <0.03 mg/mmol, n=32 ≥0.03 mg/mmol, n=53 Odds Ratio (95% Confidence Interval) P Value
Peak serum creatinine, mg/dl 1.06 (0.77–1.54) 1.79 (1.13–3.79) <0.001 0.92 (0.77–1.19) 1.44 (0.99–1.44) 0.004
AKI, all stages 36 (31) 52 (62) 3.61 (2.02 to 6.58) <0.001 6 (19) 28 (52) 5.24 (1.95 to 15.98) 0.002
 Stage 1 15 (13) 13 (15) 4 (12) 11 (21)
 Stage 2 10 (9) 14 (17) 1 (3) 8 (15)
 Stage 3 11 (9) 25 (30) 1 (3) 9 (17)
KRT 7 (6) 20 (24) 4.87 (2.03 to 13.00) <0.001 0 (0) 6 (11)
ICU required 55 (47) 64 (76) 3.55 (1.93 to 6.71) <0.001 8 (25) 41 (77) 10.25 (3.82 to 30.23) <0.001
Death 21 (18) 37 (44) 3.56 (1.90 to 6.54) <0.001 1 (3) 21 (40) 22 (4.21 to 406) <0.001

Quantitative values are given as medians (interquartile ranges), and qualitative values are given as number of patients/percentage. Odds ratios and P values are given for unadjusted analysis. ICU, intensive care unit.